Stocks To Buy Now

Blog


Continental Stock Transfer & Trust Maintains Steady Course of Decades-Long Excellence

Established in 1964, family-owned Continental Stock Transfer & Trust has remained on track to achieve its vision of fully supporting emerging and growth companies with superior attention and uniquely tailored business solutions.

Accomplishing this steady path requires strong company management capable of leading a staff of some of the industry’s most experienced experts. Together, these individuals serve companies with up to 50,000 shareholders with a range of fundamental offerings, including record keeping, maintaining shareholder information, issuance and transfer of shares, shareholder communication, dividend disbursement and tax reporting, stock plan administration, escrow services, annual meeting and proxy services and much more.

In addition to transfer agent essentials, Continentals’ extended offerings include employee plan administration, IPO and SPAC services, annual meeting and proxy services, corporate actions and escrow services, EDGAR/XBRL filing, stock plan administration, dividend reinvestment plan and direct purchase plan administration, and dividend disbursement services.
For shareholders, Continental offers:

• Immediate responses to phone inquiries and same-day responses to email inquiries
• Secure 24/7 online account access via ContinentaLink
• Online access to important IRS and other forms and documents
• Definitions of key terms and answers to frequently asked questions
• Online proxy voting

As a long-standing, reputable agent in the United States, Continental provides each company with personal attention from senior staff, flexible offerings and innovative technology – all of which contribute to the company’s stellar track record of superior customer satisfaction.

For more information visit www.continentalstock.com

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Advances Ricin Vaccine amid Toxin Threat

December 19, 2025

A recent “Times of India” report spotlighted the danger posed by ricin, a highly toxic plant-derived compound with no known antidote and a history of attempted misuse by extremist actors. Soligenix (NASDAQ: SNGX), a biopharmaceutical company focused on biodefense solutions, is developing a vaccine candidate known as RiVax(R) to protect against ricin exposure, positioning the company’s work at the […]

Rotate your device 90° to view site.